INEB Competitors

At PreventionGenetics, we are passionate about human genetics and its power to improve lives. Located in Marshfield, WI, PrevetionGenetics was founded in 2004 and acquired in 2022 by global cancer diagnostics leader, Exact Sciences. PreventionGenetics is a CLIA and ISO 15189:2012 accredited laboratory, delivering high-quality genetic testing at fair prices with exemplary service to patients, researchers and clinicians around the world. We provide tests for nearly all clinically relevant genes including our powerful and comprehensive whole-genome sequencing test, PGnome®, and whole-exome sequencing test, PGxome®. In the changing landscape of genetic testing, our quality and commitment to clinicians, researchers and patients remains unchanged. We stay on the forefront of clinical genetics and consistently expand and update our test menu, introduce new technologies and increase the efficiency of our processes. Content reflects information available and is accurate at the time of publication.

Genomind is a leading precision health company focused on optimizing the treatment experience for individuals and healthcare providers through actionable genetic insights and innovative health technology. Since its founding, Genomind has expanded beyond its flagship of pharmacogenetic testing to develop a comprehensive portfolio of precision health services for individual and population-level patient care. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management, and a new standard of care. Genomind's Pharmacogenetic Test is an industry-leading prescription genetic test that equips healthcare professionals with tools they need to more quickly identify a personalized treatment plan for their patients. Genomind offers more comprehensive genetic guidance, superior speed and accuracy, state-of-the-art digital tools, and scheduled PhD and PharmD expert consultations. This test is available via clinician order only. Genomind® Mental Health Map™ is the first-ever genetic test available direct-to-consumer designed specifically for mental health and wellness. It provides powerful new insights and actions through reports in the 7 Core Genetic Mental Health Capabilities™ by analyzing genetic makeup across 35 genes, 38 genetic variants, 21 genetic mechanisms, and 59 mental health predispositions. Included is a free consult to help individuals better take advantage of their results. This test does not inform on medications nor require clinician order. If you are a patient who is interested in our testing, or a clinician interested in using these tools in your practice, please contact us at 877-895-8658 or customerservice@genomind.com. Learn more at www.genomind.com.

Precision Genetics provides full-scale lab and genetics testing solutions including COVID, and pharmacogenomics (PGx) for perioperative and mental health to improve overall patient outcomes. By combining evidence-based technology and population risk analysis into a comprehensive and actionable solution, we allow busy providers to immediately deliver individualized treatment and prevention plans for their patients. Additionally, we allow employers to see the benefits of lowering costs around both prescription- spending and overall healthcare while employing a healthier, more engaged staff. This comprehensive, personalized approach reduces interaction and efficacy risks while ensuring proper medications are being used for therapies. Precision Genetics combines genetic markers, molecular data, and clinical evidence into a comprehensive and actionable report, allowing busy physicians and providers to immediately develop individualized treatment and prevention plans for their patients. This comprehensive, personalized approach reduces interaction and efficacy risks while assuring proper therapy. Our interactive tools empower patients to utilize their molecular results to address their individual risks and treatment pathways based on their unique genetics, demographics, lifestyle, and medical conditions. Most importantly, a patient’s genetic risk analysis can be applied later in life as their risks increase; their health changes or new treatment pathways are identified.